Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. [electronic resource]
Producer: 20140506Description: 179-82 p. digitalISSN:- 1099-1069
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Boronic Acids -- administration & dosage
- Bortezomib
- Female
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Neoplasm Proteins -- antagonists & inhibitors
- Off-Label Use
- Peripheral Nervous System Diseases -- chemically induced
- Protein Kinase Inhibitors -- adverse effects
- Pyrazines -- administration & dosage
- Remission Induction
- Retrospective Studies
- Rituximab
- Signal Transduction -- drug effects
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.